Cantel Medical Corp. (NYSE:CMN) Chairman Charles M. Diker sold 7,000 shares of the firm’s stock in a transaction on Wednesday, October 19th. The shares were sold at an average price of $76.33, for a total value of $534,310.00. Following the completion of the sale, the chairman now owns 3,174,975 shares of the company’s stock, valued at $242,345,841.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Cantel Medical Corp. (NYSE:CMN) traded down 0.50% during trading on Wednesday, reaching $75.73. The company had a trading volume of 71,058 shares. Cantel Medical Corp. has a 12-month low of $55.01 and a 12-month high of $81.63. The firm has a market capitalization of $3.13 billion, a PE ratio of 52.66 and a beta of 1.59. The firm’s 50 day moving average price is $78.00 and its 200 day moving average price is $71.33.

Cantel Medical Corp. (NYSE:CMN) last released its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.11. The firm earned $179 million during the quarter. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The business’s revenue was up 18.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 earnings per share. Analysts anticipate that Cantel Medical Corp. will post $1.98 earnings per share for the current year.

Insider Buying and Selling by Quarter for Cantel Medical Corp. (NYSE:CMN)

The business also recently announced a semiannual dividend, which will be paid on Tuesday, January 31st. Stockholders of record on Tuesday, January 17th will be given a dividend of $0.07 per share. This represents a dividend yield of 0.18%. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06. The ex-dividend date is Thursday, January 12th. Cantel Medical Corp.’s dividend payout ratio is presently 8.33%.

Hedge funds have recently added to or reduced their stakes in the stock. State Street Corp increased its stake in Cantel Medical Corp. by 1.4% in the first quarter. State Street Corp now owns 698,437 shares of the company’s stock worth $49,838,000 after buying an additional 9,417 shares during the last quarter. UBS Group AG boosted its position in Cantel Medical Corp. by 2.6% in the first quarter. UBS Group AG now owns 52,630 shares of the company’s stock worth $3,756,000 after buying an additional 1,348 shares during the period. BlackRock Group LTD boosted its position in Cantel Medical Corp. by 9.5% in the first quarter. BlackRock Group LTD now owns 42,830 shares of the company’s stock worth $3,056,000 after buying an additional 3,701 shares during the period. Acrospire Investment Management LLC boosted its position in Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock worth $102,000 after buying an additional 500 shares during the period. Finally, Bogle Investment Management L P DE acquired a new position in Cantel Medical Corp. during the first quarter worth approximately $228,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

A number of brokerages have recently weighed in on CMN. Benchmark Co. set a $83.00 target price on Cantel Medical Corp. and gave the company a “buy” rating in a research note on Saturday, October 1st. Needham & Company LLC began coverage on Cantel Medical Corp. in a research note on Wednesday, August 24th. They issued a “hold” rating for the company.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

5 Day Chart for NYSE:CMN

Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.